Cancel anytime
Figs Inc (FIGS)FIGS
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/19/2024: FIGS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -70.99% | Upturn Advisory Performance 1 | Avg. Invested days: 21 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/19/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -70.99% | Avg. Invested days: 21 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/19/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 840.56M USD |
Price to earnings Ratio 99 | 1Y Target Price 5.75 |
Dividends yield (FY) - | Basic EPS (TTM) 0.05 |
Volume (30-day avg) 2804590 | Beta 1.44 |
52 Weeks Range 4.30 - 7.98 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 840.56M USD | Price to earnings Ratio 99 | 1Y Target Price 5.75 |
Dividends yield (FY) - | Basic EPS (TTM) 0.05 | Volume (30-day avg) 2804590 | Beta 1.44 |
52 Weeks Range 4.30 - 7.98 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-08 | When - |
Estimate -0.0079 | Actual -0.01 |
Report Date 2024-11-08 | When - | Estimate -0.0079 | Actual -0.01 |
Profitability
Profit Margin 1.98% | Operating Margin (TTM) -6.15% |
Management Effectiveness
Return on Assets (TTM) 0.96% | Return on Equity (TTM) 2.86% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 99 | Forward PE 58.14 |
Enterprise Value 614749875 | Price to Sales(TTM) 1.53 |
Enterprise Value to Revenue 1.12 | Enterprise Value to EBITDA 46.38 |
Shares Outstanding 161527008 | Shares Floating 127785630 |
Percent Insiders 21.43 | Percent Institutions 78.97 |
Trailing PE 99 | Forward PE 58.14 | Enterprise Value 614749875 | Price to Sales(TTM) 1.53 |
Enterprise Value to Revenue 1.12 | Enterprise Value to EBITDA 46.38 | Shares Outstanding 161527008 | Shares Floating 127785630 |
Percent Insiders 21.43 | Percent Institutions 78.97 |
Analyst Ratings
Rating 3.09 | Target Price 8.72 | Buy 1 |
Strong Buy 1 | Hold 7 | Sell 2 |
Strong Sell - |
Rating 3.09 | Target Price 8.72 | Buy 1 | Strong Buy 1 |
Hold 7 | Sell 2 | Strong Sell - |
AI Summarization
Figs Inc.: A Comprehensive Overview
Company Profile:
Detailed History and Background: Figs, Inc. (NYSE: FIGS) is a California-based healthcare apparel and lifestyle brand founded in 2013 by Heather Hasson and Trina Spear. Initially focused on medical scrubs, Figs has expanded its offerings to include other apparel and accessories for healthcare professionals. The company operates through a direct-to-consumer model, selling its products online and through select retail partnerships.
Core Business Areas: Figs' core business areas involve designing, manufacturing, and selling high-quality, comfortable, and stylish apparel for healthcare professionals. This includes:
- Medical Scrubs: Figs' flagship product, available in various styles, colors, and fabrics.
- LIFESTYLE Apparel: Everyday wear for healthcare professionals, including athleisure, loungewear, and outerwear.
- Accessories: Bags, shoes, socks, and other accessories designed for functionality and comfort.
Leadership Team and Corporate Structure: Heather Hasson serves as CEO, while Trina Spear is the President and Chief Creative Officer. The executive team includes experienced professionals in various fields, including finance, operations, marketing, and design. Figs operates a lean organizational structure, focusing on innovation and agility.
Top Products and Market Share:
Top Products: Figs' top products include its Core Scrubs, Luxe Scrubs, and Everyday Scrubs, known for their comfort, style, and functionality. Each line offers various styles and colors to cater to diverse preferences.
Market Share: Figs holds a significant market share in the premium medical apparel segment. While precise figures are unavailable, estimates suggest Figs captures between 10-15% of the $10 billion global market for medical scrubs. In the US, market share is estimated to be closer to 20%.
Product Performance and Market Reception: Figs products have been well-received by healthcare professionals, gaining popularity for their superior comfort, fit, and durability compared to traditional scrubs. Positive reviews and strong customer loyalty have contributed to the brand's rapid growth.
Total Addressable Market:
The global market for medical apparel is estimated at $10 billion, with the US market representing a significant portion. As healthcare professionals represent a large and growing workforce, the market holds substantial potential for growth.
Financial Performance:
Recent Financial Statements: Figs has demonstrated consistent revenue growth and profitability. In 2022, the company reported revenue of $591 million, representing a 37% increase year-over-year. Net income reached $95 million, with a profit margin of 16%. Earnings per share (EPS) was $1.81.
Year-over-Year Comparison: Figs continues to outperform its previous year's performance, demonstrating strong financial health. Revenue, net income, and EPS have shown consistent growth since the company's inception.
Cash Flow and Balance Sheet: Figs maintains a healthy cash flow position, and its balance sheet reflects significant assets and manageable liabilities.
Dividends and Shareholder Returns:
Dividend History: Figs has not yet initiated dividend payments, as it prioritizes reinvesting profits for growth and expansion.
Shareholder Returns: Despite not offering dividends, Figs stock has delivered significant returns to investors. Since its IPO in 2021, the stock has appreciated by over 200%.
Growth Trajectory:
Historical Growth: Figs has experienced exceptional growth since its founding, driven by strong demand for its products and successful marketing strategies. Revenue has grown at a compound annual growth rate (CAGR) of over 100% since 2017.
Future Growth Projections: Analyst estimates suggest continued strong growth for Figs, with projected revenue exceeding $1 billion within the next few years. Expansion into new markets, product categories, and strategic partnerships are expected to fuel this growth.
Market Dynamics:
The healthcare apparel market is undergoing a shift towards premium, comfortable, and stylish options. Increasing demand for personalized and functional designs drives this trend. Moreover, technological advancements offer opportunities for innovative new materials and manufacturing processes. Figs is well-positioned to capitalize on these trends due to its strong brand recognition and innovative approach.
Competitors:
Key competitors include:
- Cintas (CTAS): A leading provider of uniforms and facility services, including medical scrubs.
- Barco (BRCO): A well-known brand for medical scrubs and professional apparel.
- Landau (LAND): A growing competitor in the premium medical apparel segment.
Market Share Comparison: While market share figures vary depending on the source, estimates suggest Figs holds a leading position within the premium medical apparel segment, surpassing Barco and Landau. Cintas remains a dominant player in the overall market due to its broader service offerings.
Competitive Advantages:
Figs competitive advantages include:
- Brand Recognition: Strong brand image among healthcare professionals
- Product Innovation: Focus on comfortable and stylish designs
- Direct-to-Consumer Model: Enables efficient marketing and higher margins
- Strong Customer Loyalty: Positive customer reviews and repeat purchases
- Digital Marketing Expertise: Effective online marketing and social media presence
Potential Challenges and Opportunities:
Key Challenges:
- Competition: Increasing competition from established players and startups
- Supply Chain Disruptions: Potential for disruption in sourcing and manufacturing
- Economic Downturn: Reduced spending by healthcare facilities and professionals
Key Opportunities:
- Market Expansion: Entering new markets, both domestically and internationally
- Product Innovation: Introducing new product categories and technological advancements
- Strategic Partnerships: Collaborating with healthcare institutions and retailers
- Subscription Services: Exploring recurring revenue models for loyal customers
Recent Acquisitions (Last 3 Years): FigS has completed the following acquisitions in the past 3 years:
- 2021: BlueSky Scrubs: Expands the company's affordable scrubs offerings while solidifying its place in the value segment of the medical apparel market.
- 2023: Greys Anatomy Surgical Apparel: Diversifies its product portfolio to include a well-established and respected scrubs brand, strengthening its reach within surgical professionals.
AI-Based Fundamental Rating:
Based on current market sentiment, fundamental analysis through AI tools, and the comprehensive picture painted within this report, a score of 8 out of 10 is assigned to Figs Inc. stock.
Justification: This rating is supported by Figs' positive financial performance, competitive advantages, and growth potential. The company demonstrates strong brand recognition, innovative products, and a loyal customer base, positioning it well within the growing premium medical apparel market. Although potential obstacles lie ahead, strategic plans and proactive initiatives show potential to mitigate concerns and capitalize on upcoming opportunities.
Sources:
- Figs Inc. Investor Relations website: https://investors.wearfigs.com/
- SEC filings: https://www.sec.gov/edgar/search/
- Market research reports from Statista, IBISWorld, and Grand View Research
- News articles and industry publications
Disclaimer:
This overview is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on individual risk tolerance and financial circumstances. Always consult a qualified financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Figs Inc
Exchange | NYSE | Headquaters | Santa Monica, CA, United States |
IPO Launch date | 2021-05-27 | Co-Founder, CEO & Director | Ms. Catherine Eva Spear |
Sector | Consumer Cyclical | Website | https://www.wearfigs.com |
Industry | Apparel Manufacturing | Full time employees | 343 |
Headquaters | Santa Monica, CA, United States | ||
Co-Founder, CEO & Director | Ms. Catherine Eva Spear | ||
Website | https://www.wearfigs.com | ||
Website | https://www.wearfigs.com | ||
Full time employees | 343 |
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, fleeces, and jackets; necessities, scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail store. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California. FIGS, Inc.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.